Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Edesa Biotech stock

Learn how to easily invest in Edesa Biotech stock.

Edesa Biotech Inc is a biotechnology business based in the US. Edesa Biotech shares (EDSA) are listed on the NASDAQ and all prices are listed in US Dollars. Edesa Biotech employs 16 staff and has a trailing 12-month revenue of around $500.

How to buy shares in Edesa Biotech

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EDSA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Edesa Biotech stock price (NASDAQ: EDSA)

Use our graph to track the performance of EDSA stocks over time.

Edesa Biotech shares at a glance

Information last updated 2022-10-03.
Latest market close$1.14
52-week range$0.90 - $8.95
50-day moving average $1.77
200-day moving average $2.79
Wall St. target price$16.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.13

Buy Edesa Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Edesa Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Edesa Biotech price performance over time

Historical closes compared with the close of $1.14 from 2022-10-04

1 week (2022-09-29) -19.72%
1 month (2022-09-06) -32.54%
3 months (2022-07-06) -33.72%
6 months (2022-04-06) -59.29%
1 year (2021-10-06) -84.06%
2 years (2020-10-06) -85.38%
3 years (2019-10-04) 6.42
5 years (2017-10-05) 1.1446

Edesa Biotech financials

Revenue TTM $500
Gross profit TTM $311,200
Return on assets TTM -76.34%
Return on equity TTM -133.29%
Profit margin 0%
Book value $0.77
Market capitalisation $14.2 million

TTM: trailing 12 months

Edesa Biotech share dividends

We're not expecting Edesa Biotech to pay a dividend over the next 12 months.

Have Edesa Biotech's shares ever split?

Edesa Biotech's shares were split on a 1:6 basis on 9 June 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Edesa Biotech shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Edesa Biotech shares which in turn could have impacted Edesa Biotech's share price.

Edesa Biotech share price volatility

Over the last 12 months, Edesa Biotech's shares have ranged in value from as little as $0.9 up to $8.95. A popular way to gauge a stock's volatility is its "beta".

EDSA.US volatility(beta: 1.52)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Edesa Biotech's is 1.516. This would suggest that Edesa Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Edesa Biotech overview

Edesa Biotech, Inc. , a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada. .

Frequently asked questions

What percentage of Edesa Biotech is owned by insiders or institutions?
Currently 21.826% of Edesa Biotech shares are held by insiders and 22.513% by institutions.
How many people work for Edesa Biotech?
Latest data suggests 16 work at Edesa Biotech.
When does the fiscal year end for Edesa Biotech?
Edesa Biotech's fiscal year ends in September.
Where is Edesa Biotech based?
Edesa Biotech's address is: 100 Spy Court, Markham, ON, Canada, L3R 5H6
What is Edesa Biotech's ISIN number?
Edesa Biotech's international securities identification number is: CA27966L1085
What is Edesa Biotech's CUSIP number?
Edesa Biotech's Committee on Uniform Securities Identification Procedures number is: 27966L108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site